They also demonstrate that a relatively short treatment with a selective calpain-2 inhibitor initiated shortly after concussion represents a novel therapeutic approach to prevent brain damage and behavioral modifications resulting from both severe and acute as well as mild repeated concussions. The gene discussed is CAPN2; the disease is brain injury.